Definition of the intermediates and mechanism of the anticancer drug bleomycin using nuclear resonance vibrational spectroscopy and related methods

Nuclear Resonance Vibrational Spectroscopy Applied to [Fe(OEP)(NO)]: The Vibrational Assignments of Five-Coordinate Ferrous Heme−Nitrosyls and Implications for Electronic Structure

(2010) Nicolai Lehnert et al.   INORGANIC CHEMISTRY

Oriented Single-Crystal Nuclear Resonance Vibrational Spectroscopy of [Fe(TPP)(MI)(NO)]: Quantitative Assessment of thetransEffect of NO

(2010) Nicolai Lehnert et al.   INORGANIC CHEMISTRY

A Hydrogen-Bond Facilitated Cycle for Oxygen Reduction by an Acid- and Base-Compatible Iron Platform

(2009) Han Sen Soo et al.   INORGANIC CHEMISTRY

Peroxo-Type Intermediates in Class I Ribonucleotide Reductase and Related Binuclear Non-Heme Iron Enzymes

(2009) Kasper P. Jensen et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

A Combined NRVS and DFT Study of FeIVO Model Complexes: A Diagnostic Method for the Elucidation of Non-Heme Iron Enzyme Intermediates

(2008) Caleb B. Bell et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Crystal structure of DNA-bound Co(III)·bleomycin B2: Insights on intercalation and minor groove binding

(2008) Kristie D. Goodwin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Further insights into the mechanism of the reaction of activated bleomycin with DNA

(2008) M. S. Chow et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA